Reilly JT - Search Results

Year	Number of Results
1983	3
1984	2
1985	3
1986	1
1988	2
1989	2
1990	3
1991	5
1992	3
1993	2
1994	8
1995	8
1996	6
1997	4
1998	6
1999	3
2000	7
2001	8
2002	9
2003	10
2004	7
2005	12
2006	10
2007	10
2008	9
2009	8
2010	7
2011	4
2012	7
2013	3
2014	6
2015	4
2016	1
2021	1
2023	1
2025	0

1

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.

Cervantes F, Dupriez B, Pereira A, Passamonti F, Reilly JT, Morra E, Vannucchi AM, Mesa RA, Demory JL, Barosi G, Rumi E, Tefferi A. Cervantes F, et al. Among authors: reilly jt. Blood. 2009 Mar 26;113(13):2895-901. doi: 10.1182/blood-2008-07-170449. Epub 2008 Nov 6. Blood. 2009. PMID: 18988864 Free article.

2

Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis.

McMullin MF, Bareford D, Campbell P, Green AR, Harrison C, Hunt B, Oscier D, Polkey MI, Reilly JT, Rosenthal E, Ryan K, Pearson TC, Wilkins B; General Haematology Task Force of the British Committee for Standards in Haematology. McMullin MF, et al. Among authors: reilly jt. Br J Haematol. 2005 Jul;130(2):174-95. doi: 10.1111/j.1365-2141.2005.05535.x. Br J Haematol. 2005. PMID: 16029446 No abstract available.

3

Idiopathic myelofibrosis: pathogenesis to treatment.

Reilly JT. Reilly JT. Hematol Oncol. 2006 Jun;24(2):56-63. doi: 10.1002/hon.771. Hematol Oncol. 2006. PMID: 16477581 Review.

4

Optimal Generators for Quantum Sensing.

Reilly JT, Wilson JD, Jäger SB, Wilson C, Holland MJ. Reilly JT, et al. Phys Rev Lett. 2023 Oct 13;131(15):150802. doi: 10.1103/PhysRevLett.131.150802. Phys Rev Lett. 2023. PMID: 37897766

5

Class III receptor tyrosine kinases: role in leukaemogenesis.

Reilly JT. Reilly JT. Br J Haematol. 2002 Mar;116(4):744-57. doi: 10.1046/j.0007-1048.2001.03294.x. Br J Haematol. 2002. PMID: 11886377 Review. No abstract available.

6

Chronic neutrophilic leukaemia: a distinct clinical entity?

Reilly JT. Reilly JT. Br J Haematol. 2002 Jan;116(1):10-8. doi: 10.1046/j.1365-2141.2002.03234.x. Br J Haematol. 2002. PMID: 11841395 Review. No abstract available.

7

Prognosis and survivorship in primary myelofibrosis.

Reilly JT. Reilly JT. Am J Hematol. 2010 Jan;85(1):4-5. doi: 10.1002/ajh.21586. Am J Hematol. 2010. PMID: 20029947 Free article. No abstract available.

8

Pathogenesis of idiopathic myelofibrosis: role of growth factors.

Reilly JT. Reilly JT. J Clin Pathol. 1992 Jun;45(6):461-4. doi: 10.1136/jcp.45.6.461. J Clin Pathol. 1992. PMID: 1624590 Free PMC article. Review. No abstract available.

9

Receptor tyrosine kinases in normal and malignant haematopoiesis.

Reilly JT. Reilly JT. Blood Rev. 2003 Dec;17(4):241-8. doi: 10.1016/s0268-960x(03)00024-9. Blood Rev. 2003. PMID: 14556779 Review.

10

Interferon treatment in polycythaemia vera.

Reilly JT, Vellenga E, De Wolff JT. Reilly JT, et al. Leuk Lymphoma. 1996 Sep;22 Suppl 1:143-8. doi: 10.3109/10428199609074372. Leuk Lymphoma. 1996. PMID: 8951785 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Results by year